Search

Search Constraints

You searched for: Author/Creator Liebisch, Peter

Search Results

1. Bortezomib consolidation following autologous transplant in younger and older patients with newly diagnosed multiple myeloma in two phase III trials. (19th July 2019)

2. Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma. (28th August 2021)

3. Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial. (29th September 2017)

4. Targeted sequencing using a 47 gene multiple myeloma mutation panel (M3P) in ‐17p high risk disease. (10th October 2014)